American Eagle has been working to boost profit over the next three years and has drilled down on revamping its product assortment.
Kategorie-Archiv: CNBC Financial News
Now you can invest in Elon Musk’s xAI through Cathie Wood’s ARK Venture Fund
Cathie Wood’s ARK Invest has taken a stake in Elon Musk’s startup xAI as she deepens her big bet on artificial intelligence.
Med tech stock Semler Scientific takes bitcoin play from MicroStrategy’s book, surges 37%
Semler Scientific saw its shares surge Tuesday after it said it has adopted bitcoin as its primary treasury reserve asset.
Clean Energy Ventures raises $305 million to back early-stage climate startups
Clean energy stocks may be underperforming in the public market, but in private markets, there is still an appetite for companies focused on decarbonization.
IMF upgrades China’s growth forecast to 5% on ’strong‘ first quarter and policy measures
The International Monetary Fund raised its forecast for China’s growth this year to 5%, from 4.6% previously, due to „strong“ first quarter figures and policy moves.
Chinese travelers are opting for lower-cost domestic destinations over foreign tourist spots
Cost-conscious Chinese consumers are increasingly picking cheaper tourist destinations at home instead of going overseas.
Abercrombie & Fitch shares jump more than 10% as retailer’s torrid growth continues
Abercrombie & Fitch is building on its blockbuster 2023 by growing Hollister and adding new categories to its namesake banner, such as the A&F Wedding Shop.
Dick’s Sporting Goods raises guidance, says shoppers are spending more on sneakers and athletic gear
Dick’s Sporting Goods saw sales grow well ahead of estimates, following behind other retailers that said consumers are spending on new clothes and shoes.
Stock trade settlement moves to single day as GameStop mania underscores need for faster transactions
Wall Street is now required to settle stock trades faster after a new rule from the Securities and Exchange Commission takes effect Tuesday.
This new weight loss drug ETF bets big on two of the industry’s leading players
While Novo Nordisk and Eli Lilly have soared in the past year, Roundhill Investments sees bigger gains ahead for the GLP-1 drugmakers.